18 Table 4 Time to Improvement of Abnormalities in Vitamin B12 Deficiency After Initiation of Treatment A 2005 Cochrane review involving 108 patients with vitamin B 12 deficiency found that high-dose oral replacement (1 mg to 2 mg per day) was as effective as parenteral administration for correcting anemia and neurologic symptoms
FDA-approved for short-term use, it works by stimulating your central nervous system to help reduce hunger, increase energy, and improve motivation especially during the early phases of your transformation journey
Vitamin B12 deficiency, left untreated, can lead to pernicious anaemia or neurological problems
Peptide bioregulators: The new class of geroprotectors
well-tolerated in mice, rats, rabbits, and dogs with no serious organ toxicity.[34][35] Clinical Safety : Mild local irritation possible at injection sites, but no systemic adverse effects reported in trials.[36][37] Potential Risks : Theoretical concerns include pro-angiogenic effects potentially promoting tumor growth, though no evidence supports this in studies.[38] Long-term human data is limited, so monitoring is advised
Its distinguishing factor is functional breadth